You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 1, JANUARY 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Antithrombotic Effects of Sodium Heparin and Sodium Warfarin

JOHN C. HOAK, MD; WILLIAM E. CONNOR, MD; EMORY D. WARNER, MD

Arch Intern Med. 1966;117(1):25-31.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ALTHOUGH THE usual sequence in experimental medicine is to go from laboratory experiments to the clinic, at times it is valuable to work in the opposite direction and bring laboratory investigation to bear on problems which have not been solved by direct clinical approach. Despite the widespread clinical use of anticoagulant drugs in the treatment of thromboembolic disease, important questions remain about their antithrombotic efficacy, methods of administration, and relative effectiveness of the different drugs. It is common experience that patients with adequate anticoagulant activity as measured by in vitro tests still develop thrombosis.

At least three general approaches have been used in the production of thrombosis in animals. These involve injury to the endothelial surface of blood vessels, retardation of blood flow, and production of hypercoagulability of the blood. Usually two of the three factors are required to produce experimental thrombosis.

In the present study, jugular vein thrombosis was . . . [Full Text PDF of this Article]


Author Affiliations

IOWA CITY

From the Cardiovascular Research Laboratories of the Department of Internal Medicine (Drs. Hoak and Connor) and the Department of Pathology (Dr. Warner), University of Iowa College of Medicine, Iowa City. Dr. Hoak is an Advanced Research Fellow of the American Heart Association.


Footnotes

Received for publication June 24, 1965; accepted Aug 23.

Read in part before the 16th Annual Meeting of the Council on Arteriosclerosis of the American Heart Association, 1962.1

Reprint requests to Department of Medicine, University Hospitals, Newton Rd, Iowa City, Iowa 52241 (Dr. Hoak).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.